Biotech

All Articles

Pfizer takes $230M attacked after axing fell short DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene therapy failing has blown a $230 thousand hol...

AC Immune views 'site' possible in Alzheimer's medication information

.After much more than two decades of deal with neurodegenerative health conditions, Swiss biotech AC...

GSK goes down ph. 2 HPV vaccine over lack of best-in-class prospective

.GSK has ditched a stage 2 human papillomavirus (HPV) vaccine from its own pipe after making a decis...

OS Treatments refiles $6M IPO to money HER2 drug, preclinical ADCs

.Operating system Therapies will definitely specify on the NYSE American sell swap this morning by m...

ALX's fizzling CD47 feedback cost sends stock spiraling down

.ALX Oncology's phase 2 stomach cancer feedback price has actually weakened. After observing its own...

Ionis centers eye condition from aim ats of Roche-partnered possibility after information dissatisfy

.One More of Ionis Pharmaceuticals' crucial midphase readouts has disappointed requirements, motivat...

Biogen's chief executive officer mentioned no dangerous handle 2023. He's ready to become strong

.While Biogen's pharma peers are actually looking for late-stage assets with little risk, chief exec...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Biography has actually been a biotech looking for a pipe after it scrapped its own lead reso...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually handed back rights to an early Alzheimer's disease system to Denali Therapies, ...

Takeda taps brand-new mind people oncology service-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings ...